Analysts Anticipate Genpact Limited (G) Will Post Quarterly Sales of $641.60 Million

Analysts expect Genpact Limited (NYSE:G) to post $641.60 million in sales for the current quarter, Zacks reports. Five analysts have issued estimates for Genpact Limited’s earnings. The highest sales estimate is $653.08 million and the lowest is $633.00 million. Genpact Limited reported sales of $630.52 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 1.8%. The firm is expected to issue its next earnings results on Wednesday, August 2nd.

On average, analysts expect that Genpact Limited will report full year sales of $641.60 million for the current financial year, with estimates ranging from $2.66 billion to $2.69 billion. For the next financial year, analysts forecast that the company will report sales of $2.86 billion per share, with estimates ranging from $2.78 billion to $2.93 billion. Zacks’ sales averages are a mean average based on a survey of analysts that that provide coverage for Genpact Limited.

Genpact Limited (NYSE:G) last issued its quarterly earnings results on Thursday, May 4th. The business services provider reported $0.29 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.29. Genpact Limited had a net margin of 10.23% and a return on equity of 22.24%. The firm had revenue of $623 million during the quarter, compared to the consensus estimate of $614.84 million. During the same period in the prior year, the firm earned $0.31 EPS. The business’s revenue was up 2.2% on a year-over-year basis.

G has been the subject of a number of recent research reports. Zacks Investment Research raised shares of Genpact Limited from a “sell” rating to a “hold” rating in a research report on Tuesday, February 28th. Jefferies Group LLC reaffirmed a “buy” rating on shares of Genpact Limited in a research report on Friday, March 17th. Finally, BMO Capital Markets reaffirmed a “hold” rating and set a $25.00 price objective on shares of Genpact Limited in a research report on Thursday, March 23rd. One analyst has rated the stock with a sell rating, one has assigned a hold rating and six have given a buy rating to the stock. Genpact Limited has an average rating of “Buy” and a consensus target price of $28.38.

WARNING: This piece of content was reported by sleekmoney and is the property of of sleekmoney. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://sleekmoney.com/analysts-anticipate-genpact-limited-g-will-post-quarterly-sales-of-641-60-million/1916376.html.

Shares of Genpact Limited (NYSE:G) traded down 1.64% during mid-day trading on Friday, reaching $27.05. 1,501,471 shares of the company’s stock were exchanged. The stock has a market cap of $5.21 billion, a price-to-earnings ratio of 21.25 and a beta of 0.53. Genpact Limited has a 52-week low of $22.58 and a 52-week high of $27.87. The stock’s 50-day moving average is $26.36 and its 200-day moving average is $24.79.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 28th. Stockholders of record on Monday, June 12th will be paid a $0.06 dividend. This represents a $0.24 annualized dividend and a dividend yield of 0.89%. The ex-dividend date of this dividend is Thursday, June 8th. Genpact Limited’s dividend payout ratio is currently 18.75%.

In other news, Director James C. Madden sold 5,224 shares of the company’s stock in a transaction that occurred on Friday, May 12th. The stock was sold at an average price of $25.51, for a total value of $133,264.24. Following the completion of the transaction, the director now owns 8,970 shares of the company’s stock, valued at $228,824.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mohit Thukral sold 27,228 shares of the company’s stock in a transaction that occurred on Tuesday, May 30th. The shares were sold at an average price of $27.21, for a total value of $740,873.88. Following the completion of the transaction, the insider now directly owns 68,845 shares of the company’s stock, valued at approximately $1,873,272.45. The disclosure for this sale can be found here. Corporate insiders own 1.55% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the stock. Norges Bank acquired a new position in Genpact Limited during the fourth quarter worth about $32,718,000. Hudson Bay Capital Management LP acquired a new position in Genpact Limited during the fourth quarter worth about $6,319,000. Cooke & Bieler LP boosted its position in Genpact Limited by 64.9% in the first quarter. Cooke & Bieler LP now owns 731,209 shares of the business services provider’s stock worth $18,105,000 after buying an additional 287,828 shares during the last quarter. Montag & Caldwell LLC boosted its position in Genpact Limited by 31.5% in the first quarter. Montag & Caldwell LLC now owns 32,950 shares of the business services provider’s stock worth $816,000 after buying an additional 7,884 shares during the last quarter. Finally, Wetherby Asset Management Inc. boosted its position in Genpact Limited by 14.9% in the first quarter. Wetherby Asset Management Inc. now owns 13,828 shares of the business services provider’s stock worth $342,000 after buying an additional 1,796 shares during the last quarter. 93.94% of the stock is owned by institutional investors and hedge funds.

Genpact Limited Company Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Get a free copy of the Zacks research report on Genpact Limited (G)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/analysts-anticipate-genpact-limited-g-will-post-quarterly-sales-of-641-60-million/1916376.html

Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *